According to a new report from Intel Market Research, the global Rivaroxaban market was valued at USD 8,537 million in 2026 and is projected to reach USD 15,270 million by 2034, growing at a robust CAGR of 8.9% during the forecast period (2026–2034). This expansion is being driven by the rising global incidence of thromboembolic disorders, the...
English
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek